We found that the generation of GDAsBMP from GRP cells was associated with a dramatic increase in mRNA levels for GDNF, BDNF, IGF1 and neurturin, all of which are of interest as potential therapeutic agents in PD. This evidence concerns the gene GRP and Parkinson disease.